Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio

Ultra Nasdaq Biotechnology 2X ETF (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	BIB
Company	Ultra Nasdaq Biotechnology 2X ETF
Price Information
Exchange	NASDAQ
Open	47.87
High	48.68
Low	47.87
Last	47.91
Change	-0.10
% Change	-0.21%
Volume	2,577
20-Day Average Volume	46,094
Previous Close	48.01
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	53.39
20-Day Raw Stochastic	1.80%
20-Day Relative Strength	32.40%
Weighted Alpha	-17.77
Today's Opinion	24% Sell
Previous Opinion	24% Sell
Last Month's Opinion	64% Buy
Performance
5-Days
%Chg	-6.33% since 04/12/24
Low	47.87 on 04/19/24
High	51.82 on 04/15/24
1-Month
%Chg	-14.41% since 03/19/24
Low	47.87 on 04/19/24
High	58.46 on 03/21/24
3-Month
%Chg	-16.49% since 01/19/24
Low	47.87 on 04/19/24
High	62.45 on 02/27/24
6-Month
%Chg	+8.37% since 10/19/23
Low	40.10 on 10/31/23
High	62.45 on 02/27/24
Key Statistics
Market Capitalization, $K	78,256
Shares Outstanding, K	1,630
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	1.63
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	06/27/14
Most Recent Dividend	0.040 on 03/20/24
Next Ex-Dividends Date	03/20/24
Ratios
Price/Earnings ttm	0.00